RxDoctor Payments Data

Sean Christiansen

Family Medicine · Santa Maria, CANPI 1215383708

Payments from drug & device makers

$8,080in general payments, 2019–2025

Across 520 payments — averaging $15.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • AbbVie$1K
  • Novo Nordisk$967
  • GSK$545
  • Lilly USA, LLC$532
  • Pfizer$427
  • plus $3K from 35 others

What the payments were for

  • Food & beverage$8,080100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,080 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$139,018
Medicare patients
349
Services billed
1,338

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin54$72,387
OzempicSemaglutide39$42,875
Repatha SureclickEvolocumab26$35,402
EliquisApixaban19$29,951
MounjaroTirzepatide27$27,593
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$25,173
Nurtec OdtRimegepant Sulfate22$25,055
XareltoRivaroxaban29$22,743
FarxigaDapagliflozin Propanediol12$19,469
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$4,779
Tresiba Flextouch U-100Insulin Degludec12$4,637
Rosuvastatin Calcium133$3,054
Ezetimibe53$2,549
Levothyroxine Sodium190$2,418
Albuterol Sulfate HfaAlbuterol Sulfate76$2,004

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$299$72,38754 claims
PfizerEliquis, Nurtec Odt$427$55,00741 claims
Novo NordiskOzempic$967$42,87539 claims
GSKTrelegy Ellipta, Anoro Ellipta$545$29,95236 claims
Lilly USA, LLCMounjaro$532$27,59327 claims
Johnson & JohnsonXarelto$205$22,74329 claims
AstraZenecaFarxiga$352$19,46912 claims
AbbVieSynthroid$1,345$1,97922 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,533 family medicine providers in California.

Other family medicine in Santa Maria

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →